Analytical Power Tools Open Upstream Bioprocessing Bottlenecks
29 Jan 2019![](https://cdn.sanity.io/images/f5b6mtfn/selectscience-prod/b6caf76332b12d845ce3e5daa35194953002b11d-200x200.jpg?w=256&q=75&fit=clip&auto=format)
The blockbuster success of antibody-based therapeutics for autoimmune diseases, inflammatory diseases and immuno-oncology accelerated the high stakes monoclonal antibody (mAb) development race. Clone selection is a significant upstream bottle-neck slowing bench-to-bedside development progress for new mAb-based therapeutics.
Cy-Clone™ PLUS, a validated assay kit accelerates human mAb production cell-line generation, significantly reducing the time to industrial-scale productivity. The Intellicyt® Cy-Clone PLUS assay combined with the Intellicyt® iQue Screener PLUS with ForeCyt® Software are the powerful analytical tools that inform rapid go/no-go decisions with multiparameter, high-content data from a single-path workflow.
Download this white paper to learn more.
![](https://cdn.sanity.io/images/f5b6mtfn/selectscience-prod/a2b09c8bbbfa5e92061b207effa72f963ce91a1e-805x238.jpg?w=828&q=75&fit=clip&auto=format)